Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
40,725,846
-
Shares change
-
+2,216,565
-
Total reported value, excl. options
-
$2,759,699,220
-
Value change
-
+$146,474,004
-
Put/Call ratio
-
80%
-
Number of buys
-
84
-
Number of sells
-
81
-
Price
-
$67.78
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2017
As of 31 Mar 2017 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,725,846 shares of stock of the company.
Largest 10 holders included FMR LLC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, and CAPITAL GUARDIAN TRUST CO.
This table shows 203 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.